Screener
SELLAS Life Sciences Group, Inc. SLS Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The source filing: SELLAS Life Sciences Group, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001390478-26-000012
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $3,086 | $2,948 |
| Accrued expenses and other current liabilities | 3,903 | 3,525 |
| Operating lease liabilities | 580 | 544 |
| Total current liabilities | 7,569 | 7,017 |
| Operating lease liabilities, non-current | 157 | 457 |
| Total liabilities | 7,726 | 7,474 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is SELLAS Life Sciences Group, Inc.'s accrued expenses?
- SELLAS Life Sciences Group, Inc. (SLS) reported accrued expenses of $3.9M in Q2 2026.
- How has SELLAS Life Sciences Group, Inc.'s accrued expenses changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s accrued expenses increased by 87.4% year-over-year, from $2.08M to $3.9M.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s accrued expenses has grown at a 13.0% compound annual growth rate (CAGR), from $1.91M to $3.53M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about SELLAS Life Sciences Group, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude